BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 8900282)

  • 1. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current.
    Barhanin J; Lesage F; Guillemare E; Fink M; Lazdunski M; Romey G
    Nature; 1996 Nov; 384(6604):78-80. PubMed ID: 8900282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.
    Sanguinetti MC; Curran ME; Zou A; Shen J; Spector PS; Atkinson DL; Keating MT
    Nature; 1996 Nov; 384(6604):80-3. PubMed ID: 8900283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel.
    Tinel N; Diochot S; Borsotto M; Lazdunski M; Barhanin J
    EMBO J; 2000 Dec; 19(23):6326-30. PubMed ID: 11101505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A minK-HERG complex regulates the cardiac potassium current I(Kr).
    McDonald TV; Yu Z; Ming Z; Palma E; Meyers MB; Wang KW; Goldstein SA; Fishman GI
    Nature; 1997 Jul; 388(6639):289-92. PubMed ID: 9230439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cardiac delayed rectifier K+ currents by an antisense oligodeoxynucleotide against IsK (minK) and over-expression of IsK mutant D77N in neonatal mouse hearts.
    Ohyama H; Kajita H; Omori K; Takumi T; Hiramoto N; Iwasaka T; Matsuda H
    Pflugers Arch; 2001 Jun; 442(3):329-35. PubMed ID: 11484762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants and biophysical properties of HERG and KCNQ1 channel gating.
    Tristani-Firouzi M; Sanguinetti MC
    J Mol Cell Cardiol; 2003 Jan; 35(1):27-35. PubMed ID: 12623297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current.
    London B; Trudeau MC; Newton KP; Beyer AK; Copeland NG; Gilbert DJ; Jenkins NA; Satler CA; Robertson GA
    Circ Res; 1997 Nov; 81(5):870-8. PubMed ID: 9351462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I(Kr): the hERG channel.
    Tseng GN
    J Mol Cell Cardiol; 2001 May; 33(5):835-49. PubMed ID: 11343409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
    Kang J; Chen XL; Wang L; Rampe D
    J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia.
    Sanguinetti MC
    Ann N Y Acad Sci; 1999 Apr; 868():406-13. PubMed ID: 10414310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion channels. A new wave for heart rhythms.
    Attali B
    Nature; 1996 Nov; 384(6604):24-5. PubMed ID: 8900269
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.
    Kuryshev YA; Brown AM; Wang L; Benedict CR; Rampe D
    J Pharmacol Exp Ther; 2000 Nov; 295(2):614-20. PubMed ID: 11046096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine blocks HERG, but not KvLQT1+minK, potassium channels.
    Zhang S; Rajamani S; Chen Y; Gong Q; Rong Y; Zhou Z; Ruoho A; January CT
    Mol Pharmacol; 2001 May; 59(5):1069-76. PubMed ID: 11306689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cardiac potassium currents by pentobarbital.
    Bachmann A; Mueller S; Kopp K; Brueggemann A; Suessbrich H; Gerlach U; Busch AE
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):29-37. PubMed ID: 11862331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
    Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
    Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital and acquired long QT syndrome.
    Camm AJ; Janse MJ; Roden DM; Rosen MR; Cinca J; Cobbe SM
    Eur Heart J; 2000 Aug; 21(15):1232-7. PubMed ID: 10924312
    [No Abstract]   [Full Text] [Related]  

  • 17. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
    Snyders DJ; Chaudhary A
    Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.
    Swan H; Viitasalo M; Piippo K; Laitinen P; Kontula K; Toivonen L
    J Am Coll Cardiol; 1999 Sep; 34(3):823-9. PubMed ID: 10483966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
    Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
    J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
    Busch AE; Eigenberger B; Jurkiewicz NK; Salata JJ; Pica A; Suessbrich H; Lang F
    Br J Pharmacol; 1998 Jan; 123(1):23-30. PubMed ID: 9484850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.